ASX:ARX

Aroa Biosurgery Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Aroa Biosurgery (ASX:ARX) Vs. ASE, GOLD, PGO, RLG, RFR, and ABNAF

Should you be buying ARX stock or one of its competitors? Companies in the industry of "gold" are considered alternatives and competitors to Aroa Biosurgery, including (ASE) (ASE), (GOLD.V) (GOLD), (PGO.AX) (PGO), (RLG) (RLG), 3737 (RFR), and Aben Resources (ABNAF).

Aroa Biosurgery vs. (ASE) Stock

Aroa Biosurgery (ASX:ARX) and (ASE) (CNSX:ASE) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Analyst Ratings

This is a summary of recent recommendations for Aroa Biosurgery and (ASE), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aroa Biosurgery	0	0	0	0	N/A
(ASE)	0	0	0	0	N/A

Profitability

This table compares Aroa Biosurgery and (ASE)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aroa Biosurgery	N/A	N/A	N/A
(ASE)	N/A	N/A	N/A

Earnings and Valuation

This table compares Aroa Biosurgery and (ASE)'s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aroa Biosurgery	$21.09 million	0.00	C$-87,921,977.34	A($0.29)	N/A
(ASE)	N/A	N/A	N/A	N/A	N/A

(ASE) has lower revenue, but higher earnings than Aroa Biosurgery.

Summary

Aroa Biosurgery beats (ASE) on 1 of the 1 factors compared between the two stocks.

Aroa Biosurgery vs. (GOLD.V) Stock

Aroa Biosurgery (ASX:ARX) and (GOLD.V) (CVE:GOLD) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Analyst Ratings

This is a summary of recent recommendations for Aroa Biosurgery and (GOLD.V), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aroa Biosurgery	0	0	0	0	N/A
(GOLD.V)	0	0	0	0	N/A

(GOLD.V) has a consensus target price of C$7.50, suggesting a potential upside of 733.33%.

Profitability

This table compares Aroa Biosurgery and (GOLD.V)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aroa Biosurgery	N/A	N/A	N/A
(GOLD.V)	N/A	N/A	N/A

Earnings and Valuation

This table compares Aroa Biosurgery and (GOLD.V)'s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aroa Biosurgery	$21.09 million	0.00	C$-87,921,977.34	A($0.29)	N/A
(GOLD.V)	N/A	N/A	N/A	N/A	N/A

(GOLD.V) has lower revenue, but higher earnings than Aroa Biosurgery.

Summary

Aroa Biosurgery beats (GOLD.V) on 1 of the 1 factors compared between the two stocks.

Aroa Biosurgery vs. (PGO.AX) Stock

Aroa Biosurgery (ASX:ARX) and (PGO.AX) (ASX:PGO) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Analyst Ratings

This is a summary of recent recommendations for Aroa Biosurgery and (PGO.AX), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aroa Biosurgery	0	0	0	0	N/A
(PGO.AX)	0	0	0	0	N/A

Profitability

This table compares Aroa Biosurgery and (PGO.AX)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aroa Biosurgery	N/A	N/A	N/A
(PGO.AX)	N/A	N/A	N/A

Earnings and Valuation

This table compares Aroa Biosurgery and (PGO.AX)'s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aroa Biosurgery	$21.09 million	0.00	$-87,921,977.34	A($0.29)	N/A
(PGO.AX)	N/A	N/A	N/A	N/A	N/A

(PGO.AX) has lower revenue, but higher earnings than Aroa Biosurgery.

Summary

Aroa Biosurgery beats (PGO.AX) on 1 of the 1 factors compared between the two stocks.

Aroa Biosurgery vs. (RLG) Stock

Aroa Biosurgery (ASX:ARX) and (RLG) (CNSX:RLG) are both basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Aroa Biosurgery and (RLG), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aroa Biosurgery	0	0	0	0	N/A
(RLG)	0	0	0	0	N/A

Profitability

This table compares Aroa Biosurgery and (RLG)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aroa Biosurgery	N/A	N/A	N/A
(RLG)	N/A	N/A	N/A

Earnings & Valuation

This table compares Aroa Biosurgery and (RLG)'s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aroa Biosurgery	$21.09 million	0.00	C$-87,921,977.34	A($0.29)	N/A
(RLG)	N/A	N/A	N/A	N/A	N/A

(RLG) has lower revenue, but higher earnings than Aroa Biosurgery.

Summary

Aroa Biosurgery beats (RLG) on 1 of the 1 factors compared between the two stocks.

Aroa Biosurgery vs. 3737 Stock

Aroa Biosurgery (ASX:ARX) and 3737 (CNSX:RFR) are both basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Aroa Biosurgery and 3737, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aroa Biosurgery	0	0	0	0	N/A
3737	0	0	1	0	3.00

3737 has a consensus target price of $0.12, suggesting a potential upside of ∞.

Profitability

This table compares Aroa Biosurgery and 3737's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aroa Biosurgery	N/A	N/A	N/A
3737	N/A	N/A	N/A

Earnings & Valuation

This table compares Aroa Biosurgery and 3737's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aroa Biosurgery	$21.09 million	0.00	$-87,921,977.34	A($0.29)	N/A
3737	N/A	N/A	N/A	N/A	N/A

3737 has lower revenue, but higher earnings than Aroa Biosurgery.

Aroa Biosurgery vs. Aben Resources Stock

Aroa Biosurgery (ASX:ARX) and Aben Resources (OTCMKTS:ABNAF) are both basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Aroa Biosurgery and Aben Resources, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aroa Biosurgery	0	0	0	0	N/A
Aben Resources	0	0	0	0	N/A

Profitability

This table compares Aroa Biosurgery and Aben Resources' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aroa Biosurgery	N/A	N/A	N/A
Aben Resources	N/A	N/A	N/A

Earnings & Valuation

This table compares Aroa Biosurgery and Aben Resources' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aroa Biosurgery	$21.09 million	0.00	$-87,921,977.34	A($0.29)	N/A
Aben Resources	N/A	N/A	N/A	N/A	N/A

Aben Resources has lower revenue, but higher earnings than Aroa Biosurgery.

Summary

Aroa Biosurgery beats Aben Resources on 1 of the 1 factors compared between the two stocks.